BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 20675072)

  • 1. 10-year experience with I-125 prostate brachytherapy at the Princess Margaret Hospital: results for 1,100 patients.
    Crook J; Borg J; Evans A; Toi A; Saibishkumar EP; Fung S; Ma C
    Int J Radiat Oncol Biol Phys; 2011 Aug; 80(5):1323-9. PubMed ID: 20675072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loose seeds versus stranded seeds in I-125 prostate brachytherapy: differences in clinical outcome.
    Hinnen KA; Moerland MA; Battermann JJ; van Roermund JG; Monninkhof EM; Jürgenliemk-Schulz IM; van Vulpen M
    Radiother Oncol; 2010 Jul; 96(1):30-3. PubMed ID: 20215039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostate-specific antigen kinetics following external-beam radiotherapy and temporary (Ir-192) or permanent (I-125) brachytherapy for prostate cancer.
    Pinkawa M; Piroth MD; Holy R; Fischedick K; Schaar S; Borchers H; Heidenreich A; Eble MJ
    Radiother Oncol; 2010 Jul; 96(1):25-9. PubMed ID: 20231039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes from Gleason 7, intermediate risk, localized prostate cancer treated with Iodine-125 monotherapy over 10 years.
    Munro NP; Al-Qaisieh B; Bownes P; Smith J; Carey B; Bottomley D; Ash D; Henry AM
    Radiother Oncol; 2010 Jul; 96(1):34-7. PubMed ID: 20362348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes following iodine-125 monotherapy for localized prostate cancer: the results of leeds 10-year single-center brachytherapy experience.
    Henry AM; Al-Qaisieh B; Gould K; Bownes P; Smith J; Carey B; Bottomley D; Ash D
    Int J Radiat Oncol Biol Phys; 2010 Jan; 76(1):50-6. PubMed ID: 20005453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Use of brachytherapy in the treatment of localized prostate cancer. Preliminary report].
    Rodríguez Duarte C; Mattout J; Moreira O; Jiménez R
    Arch Esp Urol; 2002 Sep; 55(7):785-91. PubMed ID: 12380306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimized prostate brachytherapy minimizes the prognostic impact of percent of biopsy cores involved with adenocarcinoma.
    Nurani R; Wallner K; Merrick G; Virgin J; Orio P; True LD
    J Urol; 2007 Nov; 178(5):1968-73; discussion 1973. PubMed ID: 17868717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term biochemical and survival outcome of 921 patients treated with I-125 permanent prostate brachytherapy.
    Hinnen KA; Battermann JJ; van Roermund JG; Moerland MA; Jürgenliemk-Schulz IM; Frank SJ; van Vulpen M
    Int J Radiat Oncol Biol Phys; 2010 Apr; 76(5):1433-8. PubMed ID: 19540075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Median 5 year follow-up of 125iodine brachytherapy as monotherapy in men agedGómez-Iturriaga Piña A; Crook J; Borg J; Lockwood G; Fleshner N
    Urology; 2010 Jun; 75(6):1412-6. PubMed ID: 20035986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical outcome of intermediate risk prostate cancer treated with iodine 125 monotherapy: The Hotel-Dieu of Quebec experience].
    Zebentout O; Apardian R; Beaulieu L; Harel F; Martin AG; Vigneault E
    Cancer Radiother; 2010 Jun; 14(3):183-8. PubMed ID: 20418145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of pretreatment and treatment factors on intermediate to long-term outcome after prostate brachytherapy.
    Stone NN; Stone MM; Rosenstein BS; Unger P; Stock RG
    J Urol; 2011 Feb; 185(2):495-500. PubMed ID: 21167528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simultaneous radiotherapy for prostate cancer: 125I prostate implant followed by external-beam radiation.
    Critz FA; Levinson AK; Williams WH; Holladay CT; Griffin VD; Holladay DA
    Cancer J Sci Am; 1998; 4(6):359-63. PubMed ID: 9853134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cesium 131 versus iodine 125 implants for prostate cancer: evaluation of early PSA response.
    Tomaszewski JJ; Smaldone MC; Makaroun S; Smith RP; Beriwal S; Benoit RM
    Can J Urol; 2010 Oct; 17(5):5360-4. PubMed ID: 20974027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypofractionated boost with high-dose-rate brachytherapy and open magnetic resonance imaging-guided implants for locally aggressive prostate cancer: a sequential dose-escalation pilot study.
    Ares C; Popowski Y; Pampallona S; Nouet P; Dipasquale G; Bieri S; Ozsoy O; Rouzaud M; Khan H; Miralbell R
    Int J Radiat Oncol Biol Phys; 2009 Nov; 75(3):656-63. PubMed ID: 19250768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conformal high dose rate brachytherapy improves biochemical control and cause specific survival in patients with prostate cancer and poor prognostic factors.
    Martinez A; Gonzalez J; Spencer W; Gustafson G; Kestin L; Kearney D; Vicini FA
    J Urol; 2003 Mar; 169(3):974-9; discussion 979-80. PubMed ID: 12576825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostate-specific antigen relapse-free survival in patients with localized prostate cancer treated by brachytherapy.
    Joseph J; Al-Qaisieh B; Ash D; Bottomley D; Carey B
    BJU Int; 2004 Dec; 94(9):1235-8. PubMed ID: 15610096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-dose radiation employing external beam radiotherapy and high-dose rate brachytherapy with and without neoadjuvant androgen deprivation for prostate cancer patients with intermediate- and high-risk features.
    Vargas C; Martínez A; Galalae R; Demanes J; Harsolia A; Schour L; Nuernberg N; Gonzalez J
    Prostate Cancer Prostatic Dis; 2006; 9(3):245-53. PubMed ID: 16786040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Summary of simultaneous irradiation for prostate cancer.
    Critz FA
    Urology; 2004 Oct; 64(4):633-6. PubMed ID: 15491686
    [No Abstract]   [Full Text] [Related]  

  • 19. Correlation between dosimetric parameters and late rectal and urinary toxicities in patients treated with high-dose-rate brachytherapy used as monotherapy for prostate cancer.
    Konishi K; Yoshioka Y; Isohashi F; Sumida I; Kawaguchi Y; Kotsuma T; Adachi K; Morimoto M; Fukuda S; Inoue T
    Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1003-7. PubMed ID: 19345517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of external radiotherapy in patients treated with permanent prostate brachytherapy.
    Potters L; Fearn P; Kattan M
    Prostate Cancer Prostatic Dis; 2002; 5(1):47-53. PubMed ID: 15195130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.